UBS Investment PT Changes for 10/27/2011
UBS has changed price targets on the following companies:
Allegiant Travel Company (NASDAQ: ALGT) Rating: Buy (Unchanged) Target: US$60 (Prior: US$58)
Brinker International (NYSE: EAT) Rating: Buy (Unchanged) Target: US$27 (Prior: US$26)
Brocade Communications Systems Inc. (NASDAQ: BRCD) Rating: Neutral (Unchanged ) Target: US$4.35 (Prior: US$3.75)
Buckeye Technologies (NYSE: BKI) Rating: Buy (Unchanged) Target: US$32 (Prior: US$30)
ConocoPhillips (NYSE: COP) Rating: Neutral (Unchanged) Target: US$68 (Prior: US$64)
Exelon Corp. (NYSE: EXC) Rating: Buy (Unchanged) Target: US$49 (Prior: US$50)
Hess Corp. (NYSE: HES) Rating: Buy (Unchanged) Target: US$79 (Prior: US$83)
LSI Corporation (NYSE: LSI) Rating: Neutral (Unchanged) Target: US$6 (Prior: US$7)
MeadWestvaco (NYSE: MWV) Rating: Buy (Unchanged) Target: US$39 (Prior: US$37)
NASDAQ OMX Group, Inc. (NASDAQ: NDAQ) Rating: Buy (Unchanged) Target: US$29 (Prior: US$28)
Novellus Systems Inc. (NASDAQ: NVLS) Rating: Neutral (Unchanged) Target: US$34 (Prior: US$31)
O'Reilly Automotive, Inc. (NASDAQ: ORLY) Rating: Buy (Unchanged) Target: US$82 (Prior: US$75)
Questar Corp (NYSE: STR) Rating: Neutral (Unchanged) Target: US$20 (Prior: US$19)
SuccessFactors, Inc. (NYSE: SFSF) Rating: Buy (Unchanged) Target: US$37 (Prior: US$40)
Symantec Corp. (NASDAQ: SYMC) Rating: Buy (Unchanged) Target: US$21 (Prior: US$22)
Thermo Fisher Scientific Inc. (NYSE: TMO) Rating: Buy (Unchanged) Target: US$60 (Prior: US$72)
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Tags: UBS Investment Research
Posted in: Price Target, Analyst Ratings
Advertisement
